Production (Stage)
Organogenesis Holdings Inc.
ORGO
$3.03
$0.155.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 86.69M | 126.66M | 115.18M | 130.23M | 109.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.69M | 126.66M | 115.18M | 130.23M | 109.98M |
| Cost of Revenue | 23.72M | 31.05M | 26.80M | 29.20M | 28.70M |
| Gross Profit | 62.97M | 95.61M | 88.38M | 101.04M | 81.28M |
| SG&A Expenses | 72.51M | 73.86M | 71.80M | 76.54M | 72.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 106.87M | 116.44M | 108.94M | 121.33M | 113.83M |
| Operating Income | -20.18M | 10.22M | 6.24M | 8.91M | -3.85M |
| Income Before Tax | -25.78M | 10.25M | 5.82M | -14.54M | -4.34M |
| Income Tax Expenses | -6.94M | 2.58M | -6.51M | 2.50M | -2.24M |
| Earnings from Continuing Operations | -18.84M | 7.67M | 12.33M | -17.04M | -2.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.84M | 7.67M | 12.33M | -17.04M | -2.10M |
| EBIT | -20.18M | 10.22M | 6.24M | 8.91M | -3.85M |
| EBITDA | -15.89M | 14.67M | 10.65M | 13.11M | 121.00K |
| EPS Basic | -0.17 | 0.05 | 0.09 | -0.13 | -0.02 |
| Normalized Basic EPS | -0.10 | 0.05 | 0.03 | 0.04 | -0.02 |
| EPS Diluted | -0.17 | 0.04 | 0.09 | -0.13 | -0.02 |
| Normalized Diluted EPS | -0.10 | 0.05 | 0.03 | 0.04 | -0.02 |
| Average Basic Shares Outstanding | 126.30M | 129.68M | 132.58M | 132.57M | 131.86M |
| Average Diluted Shares Outstanding | 126.30M | 132.16M | 133.93M | 132.57M | 131.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |